Kelun Pharmaceutical controlling shareholder adjusts share pledge

Liu Gexin, controlling shareholder of Sichuan Kelun Pharmaceutical, released a pledge on 10.5 million shares in August while simultaneously pledging 9.2 million new shares for personal funding needs.

The net reduction leaves Liu with 103.4 million pledged shares, representing 27.3% of his total holdings and 6.5% of the company's share capital. The company stated the pledge poses no immediate liquidation risk.